Monthly Newsletter

The 2nd Annual Single Cell Analysis USA Congress, 3rd 4th October 2016 in Boston, provides a unique opportunity for over 250 experts representing leading sequencing centres, global pharmaceutical organisations and world-renowned research institutions to engage in scientific discussion about the most crucial challenges in single cell analysis.

This Congress brings together a host of 250 senior level experts from, leading biotech companies and internationally renowned academic institutions. The congress will have over 60 presentations and case studies focusing on the latest innovations in single cell technologies and analysis, including sequencing technologies, transcriptome analysis, isolation methods, informatics, data handling, and single cell in oncology, immunology and other therapeutic area.

Co-located with our popular Next Generation Sequencing USA Congress, to be held on 3-4 October 2016 in Boston, 2016’s event features 6 interactive streams:

• Single Cell Analysis and Transcriptomics

• Single Cell Analysis Technologies

• Overcoming Key Single Cell Analysis Challenges

• Advances in NGS Platforms and Key Therapeutic Applications

• NGS Data Management and Bioinformatics

• NGS Clinical Applications & Diagnostics

In addition to exploring the trends outlined above, our speakers will tackle current debates in the industry such as the latest developments in single cell technologies, transcriptomics and genomics. Over two days our conference will look at approaches to sample preparation, new methods in DNA sequencing, epigenetic sequencing and RNA sequencing, informatics, data handling as well as application of single cell genomics in understanding cancer and other disease areas.

Our delegates will have the unique opportunity to hear from those working at the forefront of bioinformatics, as they will look at novel imaging techniques, and cytometry, mass spectrometry, isolation and processing of single cells. Our expert speakers will also discuss clinical applications of single cell analysis and provide the very latest case studies and data.

For further information click here